Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
antisense oligonucleotide
benzodiazepines
biogen
biotech
blackstone group
blackstone life sciences
boston
boston blog main
boston top stories
clinical trials
columbia university
david goldstein
depression
epi4k
epilepsy
essential tremor
investing
kiran reddy
life sciences
major depressive disorder
marcio souza
national blog main
national top stories
new york blog main
new york top stories
1
×
perimenopausal depression
praxis precision medicines
ptc therapeutics
1
×
startups
steven petrou
third rock ventures
university of melbourne
venture capital
1
×
What
aims
backed
cause
ceo
drugs
epilepsy
genes
genetic
links
marcio
medicines
mutations
1
×
neuro
new
praxis
precision
1
×
research
souza
1
×
stop
turn
Language
unset
Current search:
souza
×
precision
×
" new york top stories "
×
" ptc therapeutics "
×
" venture capital "
×
mutations
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs